Burden and health care resource utilization in neovascular age-related macular degeneration: Findings of a multicountry study

Archives of Ophthalmology

Volumn 125, Issue 9, 2007, Pages 1249-1254

  Soubrane, Gisèle ^a   Cruess, Alan ^b   Lotery, Andrew ^c   Pauleikhoff, Daniel ^d   Monès, Jordi ^e   Xu, Xiao ^f   Zlateva, Gergana ^g   Buggage, Ronald ^g   Conlon, John ^h   Goss, Thomas F ^f  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d ST FRANZISKUS HOSPITAL   (Germany)

^e Ocular Microsurgery Institute   (Spain)

^f Covance Market Access Services Inc   (United States)

^g PFIZER INC   (United States)

^h 206 Carnegie Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FALLING; FEMALE; FRACTURE; FUNCTIONAL ASSESSMENT; GERIATRIC PATIENT; HEALTH CARE UTILIZATION; HEALTH SURVEY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; VISION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; CANADA; CHOROIDAL NEOVASCULARIZATION; COMORBIDITY; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HEALTH RESOURCES; HEALTH SERVICES RESEARCH; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; VISUAL ACUITY;

EID: 34548604340     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.9.1249     Document Type: Article

References (28)

1. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48(3):257-293.
2. Vingerling JR, Klaver CC, Hofman A, de Jong PT. Epidemiology of age-related maculopathy. Epidemiol Rev. 1995;17(2):347-359.
3. Verma L, Das T, Binder S, et al. New approaches in the management of choroidal neovascular membrane in age-related macular degeneration. Indian J Ophthalmol. 2000;48(4):263-278.
4. Ferris FL III, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102(11):1640-1642.
5. Gottlieb JL. Age-related macular degeneration. JAMA. 2002;288(18):2233-2236.
6. Friedman DS, O'Colmain BJ, Munoz B, et al; Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564-572.
7. Bressler SB, Bressler NM, Fine SL, et al. Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration. Am J Ophthalmol. 1982;93(2):157-163.
8. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8. Arch Ophthalmol. 2001;119(10):1417-1436.
9. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD; NEI-VFQ Field Test Investigators. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116(11):1496-1504.
10. Scott IU, Smiddy WE, Schiffman J, Feuer WJ, Pappas CJ. Quality of life of low-vision patients and the impact of low-vision services. Am J Ophthalmol. 1999;128(1):54-56.
11. Chia EM, Wang JJ, Rochtchina E, Smith W, Cumming RR, Mitchell P. Impact of bilateral visual impairment on health-related quality of life: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci. 2004;45(1):71-76.
12. Hassell JB, Lamoureux EL, Keeffe JE. Impact of age related macular degeneration on quality of life. Br J Ophthalmol. 2006;90(5):593-596.
13. Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998;116(4):514-520.
14. Brown MM, Brown GC, Sharma SJ, Busbee B. Quality of life associated with visual loss: a time trade-off utility analysis comparison with medical health status. Ophthalmology. 2003;110(6):1076-1081.
15. Knur KK, Reichel MB, Gäbler P, et al. Quality of life in patients with age-related macular degeneration: a prospective study. Paper presented at: Annual Meeting of the Association for Research in Vision and Ophthalmology; April 26, 2004; Fort Lauderdale, FL.
16. Dong LM, Childs AL, Mangione CM, et al. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report No. 4. Am J Ophthalmol. 2004;138(1):91-108.
17. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050-1058.
18. EuroQol Group. EuroQol: a new facility for the measurement of health related quality of life. Health Policy. 1990;16(3):199-208.
19. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361-370.
20. Coleman AL, Stone K, Ewing SK, et al. Higher risk of multiple falls among elderly women who lose visual acuity. Ophthalmology. 2004;111(5):857-862.
21. Miskala PH, Hawkins BS, Mangione CM, et al. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization: SST report No. 1. Arch Ophthalmol. 2003;121(4):531-539.
22. Hawkins BS, Miskala PH, Bass EB, et al. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic, II: quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST report No. 10. Arch Ophthalmol. 2004;122(11):1616-1628.
23. Lindblad AS, Clemons TE. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS report No. 14. Arch Ophthalmol. 2005;123(9):1207-1214.
24. Harwood RH, Foss A, Osborn F, Gregson R, Zaman A, Masud T. Falls and health status in elderly women following first eye cataract surgery: a randomized controlled trial. Br J Ophthalmol. 2005;89(1):53-59.
25. National Institute for Clinical Excellence. Technology Appraisal Guidance 68: Guidance on the Use of Photodynamic Therapy for Age-Related Macular Degeneration. London, England: National Institute for Clinical Excellence; 2003.
26. Espallargues M, Czoski-Murray C, Bansback N, et al. The impact of age-related macular degeneration on health status utility values. Invest Ophthalmol Vis Sci. 2005;46(11):4016-4023.
27. Harwood RH. Visual problems and falls. Age Ageing. 2001;30(suppl):13-18.
28. Eichenbaum JW, Burton WB, Eichenbaum GM, Mulvihill M. The prevalence of eye disease in nursing home and non-nursing home geriatric populations. Arch Gerontol Geriatr. 1999;28(3):191-204.